期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
AAV-based gene therapy approaches for genetic forms of tauopathies and related neurogenetic disorders
1
作者 MOHAMED AGHYAD AL KABBANI GILBERT WUNDERLICH +1 位作者 CHRISTOPH KÖHLER HANS ZEMPEL 《BIOCELL》 SCIE 2022年第4期847-853,共7页
Tauopathies comprise a spectrum of genetic and sporadic neurodegenerative diseases mainly characterized by the presence of hyperphosphorylated TAU protein aggregations in neurons or glia.Gene therapy,in particular ade... Tauopathies comprise a spectrum of genetic and sporadic neurodegenerative diseases mainly characterized by the presence of hyperphosphorylated TAU protein aggregations in neurons or glia.Gene therapy,in particular adeno-associated virus(AAV)-based,is an effective medical approach for difficult-to-treat genetic diseases for which there are no convincing traditional therapies,such as tauopathies.Employing AAV-based gene therapy to treat,in particular,genetic tauopathies has many potential therapeutic benefits,but also drawbacks which need to be addressed in order to successfully and efficiently adapt this still unconventional therapy for the various types of tauopathies.In this Viewpoint,we briefly introduce some potentially treatable tauopathies,classify them according to their etiology,and discuss the potential advantages and possible problems of AAV-based gene therapy.Finally,we outline a future vision for the application of this promising therapeutic approach for genetic and sporadic tauopathies. 展开更多
关键词 TAUOPATHIES neurogenetic diseases AAV-based gene therapy Neurodegeneration Alzheimer disease TAU
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部